BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26044172)

  • 1. Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma.
    Nielsen KR; Steffensen R; Haunstrup TM; Bødker JS; Dybkær K; Baech J; Bøgsted M; Johnsen HE
    Leuk Lymphoma; 2015; 56(12):3257-66. PubMed ID: 26044172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival.
    Nielsen KR; Steffensen R; Bendtsen MD; Rodrigo-Domingo M; Baech J; Haunstrup TM; Bergkvist KS; Schmitz A; Boedker JS; Johansen P; Dybkaeær K; Boeøgsted M; Johnsen HE
    PLoS One; 2015; 10(10):e0139329. PubMed ID: 26448050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma.
    Charbonneau B; Maurer MJ; Fredericksen ZS; Zent CS; Link BK; Novak AJ; Ansell SM; Weiner GJ; Wang AH; Witzig TE; Dogan A; Slager SL; Habermann TM; Cerhan JR
    Am J Hematol; 2012 Sep; 87(9):880-5. PubMed ID: 22718493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical quantitation of diagnostic and predictive gene expression levels in follicular and diffuse large B-cell lymphoma by RT-PCR gene expression profiling.
    Sakhinia E; Glennie C; Hoyland JA; Menasce LP; Brady G; Miller C; Radford JA; Byers RJ
    Blood; 2007 May; 109(9):3922-8. PubMed ID: 17255358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
    Smedby KE; Foo JN; Skibola CF; Darabi H; Conde L; Hjalgrim H; Kumar V; Chang ET; Rothman N; Cerhan JR; Brooks-Wilson AR; Rehnberg E; Irwan ID; Ryder LP; Brown PN; Bracci PM; Agana L; Riby J; Cozen W; Davis S; Hartge P; Morton LM; Severson RK; Wang SS; Slager SL; Fredericksen ZS; Novak AJ; Kay NE; Habermann TM; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Leach S; Spinelli JJ; Smith MT; Chanock SJ; Padyukov L; Alfredsson L; Klareskog L; Glimelius B; Melbye M; Liu ET; Adami HO; Humphreys K; Liu J
    PLoS Genet; 2011 Apr; 7(4):e1001378. PubMed ID: 21533074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
    Wang SS; Maurer MJ; Morton LM; Habermann TM; Davis S; Cozen W; Lynch CF; Severson RK; Rothman N; Chanock SJ; Hartge P; Cerhan JR
    Leukemia; 2009 Mar; 23(3):596-602. PubMed ID: 18830263
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.
    Hu W; Bassig BA; Xu J; Zheng T; Zhang Y; Berndt SI; Holford TR; Hosgood HD; Leaderer B; Yeager M; Menashe I; Boyle P; Zou K; Zhu Y; Chanock S; Lan Q; Rothman N
    Environ Mol Mutagen; 2013 Jan; 54(1):72-7. PubMed ID: 23055202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host genetics in follicular lymphoma.
    Cerhan JR
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):121-34. PubMed ID: 21658613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
    Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
    Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
    Tada K; Kim SW; Asakura Y; Hiramoto N; Yakushijin K; Kurosawa S; Tajima K; Mori S; Heike Y; Tanosaki R; Maeshima AM; Taniguchi H; Furuta K; Kagami Y; Matsuno Y; Tobinai K; Takaue Y; Fukuda T
    Am J Hematol; 2012 Aug; 87(8):770-5. PubMed ID: 22641292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
    Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
    Lu Y; Abdou AM; Cerhan JR; Morton LM; Severson RK; Davis S; Cozen W; Rothman N; Bernstein L; Chanock S; Hartge P; Wang SS
    ScientificWorldJournal; 2011; 11():2062-70. PubMed ID: 22125456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma.
    Skibola CF; Bracci PM; Halperin E; Conde L; Craig DW; Agana L; Iyadurai K; Becker N; Brooks-Wilson A; Curry JD; Spinelli JJ; Holly EA; Riby J; Zhang L; Nieters A; Smith MT; Brown KM
    Nat Genet; 2009 Aug; 41(8):873-5. PubMed ID: 19620980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
    Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
    Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes.
    Al-Assar O; Rees-Unwin KS; Menasce LP; Hough RE; Goepel JR; Hammond DW; Hancock BW
    Br J Haematol; 2006 Jun; 133(6):612-21. PubMed ID: 16704435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ig gene diversification and selection in follicular lymphoma, diffuse large B cell lymphoma and primary central nervous system lymphoma revealed by lineage tree and mutation analyses.
    Zuckerman NS; McCann KJ; Ottensmeier CH; Barak M; Shahaf G; Edelman H; Dunn-Walters D; Abraham RS; Stevenson FK; Mehr R
    Int Immunol; 2010 Nov; 22(11):875-87. PubMed ID: 21059768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
    Bouska A; McKeithan TW; Deffenbacher KE; Lachel C; Wright GW; Iqbal J; Smith LM; Zhang W; Kucuk C; Rinaldi A; Bertoni F; Fitzgibbon J; Fu K; Weisenburger DD; Greiner TC; Dave BJ; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Staudt LM; Chan WC
    Blood; 2014 Mar; 123(11):1681-90. PubMed ID: 24037725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
    Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
    Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation in tumor necrosis factor and risk of diffuse large B-cell lymphoma and follicular lymphoma: differences between subgroups in Swedish patients.
    Thunberg U; Enblad G; Turesson I; Berglund M
    Leuk Lymphoma; 2010 Aug; 51(8):1563-6. PubMed ID: 20578820
    [No Abstract]   [Full Text] [Related]  

  • 20. Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
    Belotti A; Doni E; Bolis S; Rossini F; Casaroli I; Pezzatti S; Pogliani EM; Pioltelli PE
    Clin Lymphoma Myeloma Leuk; 2015 Apr; 15(4):208-13. PubMed ID: 25468321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.